Latest Regulatory News

Resolute Mining’s updated Definitive Feasibility Study for the Doropo Gold Project reveals a 55% increase in ore reserves, a longer mine life, and robust financial returns, positioning the project as a key growth driver.

Imricor Medical Systems has secured Institutional Review Board approval for the University of Virginia Health to join its VISABL-AFL clinical trial, marking a key expansion in the US. Procedures are set to begin early next year, supporting Imricor’s progress toward FDA approval and commercialisation.

Finder Energy has completed the acquisition of the Petrojarl I FPSO, gaining full control of vital infrastructure for the Kuda Tasi and Jahal project and setting the stage for a Final Investment Decision by mid-2026.

Echo IQ has formally lodged its FDA 510(k) submission for EchoSolv HF, an AI-driven heart failure diagnostic software validated by Mayo Clinic data, aiming to tap into a $60 billion US market.

New Frontier Minerals is wrapping up its first reverse circulation drilling at Harts Range, with samples now en route for assay analysis. Meanwhile, progress at the Big One Deposit mining lease signals advancing copper ambitions.

Rent.com.au has locked in up to $5.5 million in growth capital by underwriting the exercise of its remaining listed options, positioning the company for accelerated profitability and expansion of its RentBond® loan book.

Dreadnought Resources reports an initial inferred resource of 1.17 million tonnes at the Orion deposit within its Tarraji-Yampi project, highlighting significant copper, gold, silver, and cobalt grades in a strategically important region of Western Australia.

Tasman Resources has completed the second tranche of its $2 million share placement, issuing 92 million shares and raising $1.15 million before costs. The company confirms full compliance with regulatory requirements in its updated cleansing notice.

Xstate Resources has launched a prospectus offering nearly 97 million free attaching options to placement participants and contractors, alongside a nominal cleansing offer to remove trading restrictions on recent share issuances.

Apiam Animal Health Limited shareholders are set to vote on a scheme of arrangement offering $0.87 cash per share or a mix of cash and unlisted scrip in a new holding company controlled by Adamantem Capital. The Independent Expert deems the cash offer fair and reasonable, while scrip options carry liquidity and minority risks.

Assetora Limited has raised $1.535 million through three placements, including a second investment from Creative Capital Management, to advance its alternative-asset platform.

Assetora Limited has updated its previous placement announcements, confirming that the issuance of shares to Cardio Link and Creative Capital Management will now require shareholder approval at an upcoming EGM likely scheduled for late January 2026.